| Literature DB >> 26246995 |
Shengdong Wang1, Shizhen Du2, Wenjuan Zhang2, Sin Asuha3, Wen-Hua Sun2.
Abstract
Nickel(II) complexes have attracted much attention as a new generation of olefin catalysts since the α-diiminonickel complex was discovered as a highly efficient procatalyst for ethylene polymerization. A series of novel 4-arylimino-1,2,3-trihydroacridylnickel(II) dihalide complexes was synthesized in a one-pot reaction of 2,3-dihydroacridine-4-one and different anilines with nickel(II) chloride or nickel(II) bromide 1,2-dimethoxyethane complex. The complexes were characterized by infrared spectroscopy and elemental analysis. The molecular structures of the representative complexes 4-(2,6-diisopropylphenylimino)-1,2,3-trihydroacridylnickel(II) dichloride (C3), 4-(2,4,6-trimethylphenylimino)-1,2,3-trihydroacridylnickel dichloride(II) (C4), and 4-(2,4,6-trimethylphenylimino)-1,2,3-trihydroacridylnickel(II) dibromide (C9) were confirmed by single-crystal X-ray crystallography, revealing a distorted tetrahedral geometry around the nickel(II) of C3 and distorted trigonal bipyramidal geometry for C4 and C9. With the activation of trimethylaluminium (TMA), all nickel(II) complexes exhibited good activity for ethylene oligomerization, and oligomer products ranged from butene (C4) to hexadecene (C16).Entities:
Keywords: 4-arylimino-1,2,3-trihydroacridines; catalysts; ethylene; nickel(II) complexes; oligomerization
Year: 2015 PMID: 26246995 PMCID: PMC4522183 DOI: 10.1002/open.201402113
Source DB: PubMed Journal: ChemistryOpen ISSN: 2191-1363 Impact factor: 2.911
Scheme 1N,N-bidentate nickel(II) complexes.
Scheme 2Synthetic procedure for 4-arylimino-1,2,3-trihydroacridylnickel(II) dihalides. (See Experimental Section for specific reagents, conditions, and yields for the ten complexes.)
Figure 1Molecular structure of a) C3, b) C4⋅CH3OH, and c) C9⋅CH3OH. Thermal ellipsoids are shown at 30 % probability. Hydrogen atoms have been omitted for clarity.
Selected bond lengths and angles for C3, C4⋅CH3OH, and C9⋅CH3OH.
| C3(X=Cl) | C4⋅CH3OH (X=Cl) | C9⋅CH3OH (X=Br) | |
|---|---|---|---|
| Bond lengths [Å] | |||
| Ni1−N1 | 1.9979(19) | 2.082(3) | 2.082(3) |
| Ni1−N2 | 2.0014(19) | 2.037(3) | 2.022(2) |
| Ni1−X1 | 2.2210(9) | 2.2819(12) | 2.4332(8) |
| Ni1−X2 | 2.1885(8) | 2.3046(14) | 2.4432(7) |
| N1−C6 | 1.363(3) | 1.369(4) | 1.363(4) |
| N1−C9 | 1.332(3) | 1.328(4) | 1.327(4) |
| N2−C13 | 1.283(3) | 1.280(4) | 1.285(4) |
| N2−C14 | 1.448(3) | 1.444(4) | 1.453(4) |
| Bond angles [°] | |||
| N2−Ni1−N1 | 81.92(8) | 79.63(12) | 79.75(11) |
| N1−Ni1−X1 | 105.03(6) | 92.76(9) | 92.76(8) |
| N1−Ni1−X2 | 112.01(6) | 94.24(9) | 94.53(7) |
| N2−Ni1−X1 | 106.20(6) | 111.17(9) | 111.95(7) |
| N2−Ni1−X2 | 119.79(6) | 116.47(9) | 115.67(7) |
| X1−Ni1−X2 | 123.42(4) | 132.34(5) | 132.36(3) |
| N1−Ni1−O1 | 172.23(10) | 172.03(10) |
Ethylene oligomerization by nickel(II) chloride complexes C1–C5.[a]
| Run | Complex | Cocatalyst | Al/Ni | Temp [°C] | Activity[b] | Oligomer distribution[c] [%] | ||
|---|---|---|---|---|---|---|---|---|
| C4/∑C | C6/∑C | ≥C8/∑C | ||||||
| 1 | MMAO | 1000 | 30 | 3.67 | 37.9 | 22.4 | 39.7 | |
| 2 | MAO | 1000 | 30 | 2.41 | 22.3 | 8.1 | 69.6 | |
| 3 | Me2AlCl | 300 | 30 | 4.21 | 20.6 | 10.5 | 68.9 | |
| 4 | TMA | 300 | 30 | 4.95 | 41.1 | 15.3 | 43.6 | |
| 5 | TMA | 300 | 20 | 3.86 | 36.5 | 13.6 | 49.9 | |
| 6 | TMA | 300 | 40 | 3.79 | 43.0 | 9.6 | 47.4 | |
| 7 | TMA | 300 | 50 | 1.71 | 47.9 | 5.1 | 47.0 | |
| 8 | TMA | 200 | 30 | 2.11 | 35.9 | 10.4 | 54.7 | |
| 9 | TMA | 250 | 30 | 3.44 | 38.2 | 6.5 | 55.3 | |
| 10 | TMA | 350 | 30 | 3.84 | 42.0 | 12.9 | 45.1 | |
| 11 | TMA | 400 | 30 | 3.55 | 43.8 | 15.3 | 40.9 | |
| 12[d] | TMA | 300 | 30 | 6.33 | 42.1 | 12.8 | 45.1 | |
| 13[e] | TMA | 300 | 30 | 4.39 | 31.7 | 6.7 | 61.6 | |
| 14[f] | TMA | 300 | 30 | 2.63 | 31.5 | 9.3 | 59.2 | |
| 15 | TMA | 300 | 30 | 6.50 | 43.9 | 13.5 | 42.6 | |
| 16 | TMA | 300 | 30 | 5.31 | 46.4 | 6.6 | 47.0 | |
| 17 | TMA | 300 | 30 | 8.36 | 37.7 | 10.1 | 52.2 | |
| 18 | TMA | 300 | 30 | 5.74 | 48.7 | 9.3 | 42.0 | |
[a] Reagents and conditions: Ni (4 μmol), ethylene (10 atm), toluene (100 mL), 30 min; [b] unit: 105 g mol−1 (Ni) h−1; [c] Determined by GC. ∑C denotes the total amount of oligomers; [d] 15 min; [e] 45 min; [f] 60 min.
Ethylene oligomerization by nickel(II) bromide complexes C6–C10.[a]
| Run | Complex | Cocatalyst | Al/Ni | Temp [°C] | Activity[b] | Oligomer distribution[c] [%] | ||
|---|---|---|---|---|---|---|---|---|
| C4/∑C | C6/∑C | ≥C8/∑C | ||||||
| 1 | MMAO | 1000 | 30 | 5.53 | 30.5 | 20.3 | 49.2 | |
| 2 | MAO | 1000 | 30 | 3.32 | 38.4 | 12.5 | 49.1 | |
| 3 | Me2AlCl | 300 | 30 | 5.80 | 20.1 | 13.3 | 66.6 | |
| 4 | TMA | 300 | 30 | 6.31 | 47.5 | 17.6 | 34.9 | |
| 5 | TMA | 300 | 20 | 4.38 | 33.2 | 9.7 | 57.1 | |
| 6 | TMA | 300 | 40 | 5.13 | 39.5 | 10.3 | 50.2 | |
| 7 | TMA | 300 | 50 | 2.27 | 38.7 | 7.6 | 53.7 | |
| 8 | TMA | 200 | 30 | 3.08 | 40.3 | 6.6 | 53.1 | |
| 9 | TMA | 250 | 30 | 4.89 | 44.9 | 8.6 | 46.5 | |
| 10 | TMA | 350 | 30 | 5.05 | 34.6 | 12.1 | 53.3 | |
| 11 | TMA | 400 | 30 | 4.04 | 32.2 | 13.3 | 54.5 | |
| 12[d] | TMA | 300 | 30 | 9.31 | 36.7 | 9.7 | 53.6 | |
| 13[e] | TMA | 300 | 30 | 5.83 | 35.3 | 11.2 | 53.5 | |
| 14[f] | TMA | 300 | 30 | 2.32 | 31.2 | 12.8 | 56.0 | |
| 15 | TMA | 300 | 30 | 7.31 | 43.3 | 8.9 | 47.8 | |
| 16 | TMA | 300 | 30 | 6.83 | 39.7 | 12.3 | 48.0 | |
| 17 | TMA | 300 | 30 | 9.35 | 37.3 | 10.2 | 52.5 | |
| 18 | TMA | 300 | 30 | 7.22 | 40.2 | 6.3 | 53.5 | |
[a] Reagents and conditions: Ni (4 μmol), ethylene (10 atm), toluene (100 mL), 30 min; [b] unit: 105 g mol−1 (Ni) h−1; [c] Determined by GC. ∑C denotes the total amount of oligomers; [d] 15 min; [e] 45 min; [f] 60 min.
Crystallographic data and refinement details for complexes C3, C4⋅CH3OH, and C9⋅CH3OH.
| C3 | C4⋅CH3OH | C9⋅CH3OH | |
|---|---|---|---|
| Empirical formula | C25H28Cl2N2Ni | C23H25Cl2N2NiO | C23H25Br2N2NiO |
| Formula weight | 486.10 | 475.06 | 563.98 |
| Crystal color | red | yellow | yellow |
| Temp [K] | 173(2) | 173(2) | 173(2) |
| Wavelength [Å] | 0.71073 | 0.71073 | 0.71073 |
| Crystal system | Monoclinic | Triclinic | Triclinic |
| Space group | P2(1)/ | P−1 | P−1 |
| 10.025(2) | 9.838(2) | 9.946(2) | |
| 17.024(3) | 11.685(2) | 11.947(2) | |
| 13.434(3) | 11.772(2) | 11.993(2) | |
| 90 | 117.50(3) | 114.41(3) | |
| 90.48(3) | 106.93(3) | 112.80(3) | |
| 90 | 97.98(3) | 96.93(3) | |
| Volume [Å3] | 2292.6(8) | 1087.2(3) | 1127.4(3) |
| 4 | 2 | 2 | |
| Density calcd [mg m−3] | 1.408 | 1.451 | 1.661 |
| μ [mm−1] | 1.094 | 1.155 | 4.421 |
| 1016 | 494 | 566 | |
| Crystal size [mm] | 0.79×0.23×0.18 | 0.26×0.11×0.04 | 0.63×0.16×0.12 |
| 2.36–27.51 | 3.21–27.49 | 2.29–27.50 | |
| Limiting indices | −12≤ | −12≤ | −12≤ |
| −22≤ | −15≤ | −15≤ | |
| −17≤ | −15≤ | −15≤ | |
| No. of rflns collected | 16 359 | 13 856 | 14 514 |
| No. unique rflns | 5230 | 4961 | 5140 |
| 0.0510 | 0.0604 | 0.0594 | |
| Completeness to θ [%] | 99.4 | 99.4 | 99.4 |
| Goodness of fit on | 1.157 | 1.046 | 1.096 |
| Final | |||
| Largest diff peak and hole [e Å−3] | 0.447 and −0.414 | 1.461 and −1.233 | 1.306 and −0.645 |